Biogen, which developed the drug in collaboration with Sage Therapeutics, reported $27 million in sales for Zurzuvae in the first half of this year. Analysts at Jefferies have previously suggested ...
Biogen Pharmachem Industries Ltd share price was down by -0.86% from the previous closing price of ₹1.16. Who are peers of Biogen Pharmachem Industries Ltd? The peers of Biogen Pharmachem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback